XML 34 R22.htm IDEA: XBRL DOCUMENT v3.25.2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 09, 2025
shares
Jan. 07, 2025
shares
Jan. 06, 2025
shares
Jul. 01, 2024
USD ($)
Jan. 26, 2024
USD ($)
shares
Oct. 06, 2022
USD ($)
Oct. 03, 2022
Mar. 31, 2025
USD ($)
Jan. 31, 2025
shares
Jun. 30, 2012
Mar. 31, 2025
USD ($)
shares
 [1]
Jun. 30, 2024
USD ($)
shares
 [2]
Mar. 31, 2024
USD ($)
shares
Jun. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Dec. 11, 2022
USD ($)
Dec. 11, 2022
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                           3.00%          
Gross proceeds from cash fee percentage             7.00%                        
Gross proceeds from management fee percentage             1.00%                        
Stock issued during period, value, new issues                     $ 25,917 $ 2,022 $ 2,397 [3]            
Litigation settlement amount         $ 2,154                            
Liabilities current                           $ 2,727 $ 2,460        
Assets current                           32,891 $ 5,819        
Settlement amount recovery                               $ 1,100      
Legal expense                               235      
Non operating loss on legal settlement                               1,111      
Proceeds from Legal Settlements               $ 316                      
Certain Employees [Member]                                      
Loss Contingencies [Line Items]                                      
Accrued bonuses                           357          
Device [Member]                                      
Loss Contingencies [Line Items]                                      
Royalties percentage           3.00%                          
Integrated Product [Member]                                      
Loss Contingencies [Line Items]                                      
Royalties percentage           1.50%                          
Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Stock issued during period, value, new issues                     $ 139 $ 16 $ 17 [3]            
Number of share issued | shares                     13,891,840 1,566,669 1,685,682 [3]            
At-the-Market Offering Agreement [Member] | Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Aggregate offering       $ 4,820                              
Percentage of placement fee       3.00%                              
Number of share issued | shares                 842,606           3,433,880        
Securities Purchase Agreement [Member]                                      
Loss Contingencies [Line Items]                                      
Purchase price of plaintiffs                           $ 6,750          
Securities Purchase Agreement [Member] | Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Number of share issued | shares 6,103,289 3,788,550 4,000,001                                
Litigation Settlement [Member]                                      
Loss Contingencies [Line Items]                                      
Payment for litigation settlement         $ 1,100               $ 1,100            
Restricted common shares issued for legal settlement | shares         1,005,965                            
Liabilities current                               2,211      
Assets current                               $ 1,335      
Insurance recovery amount                         $ 1,335            
Litigation Settlement [Member] | Common Stock [Member]                                      
Loss Contingencies [Line Items]                                      
Number of share issued | shares                         1,005,965            
Israeli Innovation Authority [Member]                                      
Loss Contingencies [Line Items]                                      
Grants receivable                                 $ 83 ₪ 300,000  
Israeli Innovation Authority [Member] | Minimum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                           3.00%          
Israeli Innovation Authority [Member] | Maximum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                           5.00%          
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                                      
Loss Contingencies [Line Items]                                      
Repayment of government grants           $ 925                          
Ministry of Economy [Member]                                      
Loss Contingencies [Line Items]                                      
Grants receivable                           $ 50          
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                   1.50%                  
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                                      
Loss Contingencies [Line Items]                                      
Net sales royalty percenatge                   3.00%                  
H.C. Wainwright & Co. LLC [Member]                                      
Loss Contingencies [Line Items]                                      
Warrant issued, descriptions             The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to five (5.0%) percent of the aggregate number of such shares of common stock in such offerings. In addition, upon exercise for cash of any investment options by an investor, the Company has agreed to pay Wainwright a cash fee equal to 7.0% of the gross proceeds from such exercise and to issue to Wainwright or its designees additional preferred investment options equal to five (5.0%) percent of the aggregate number of shares of common stock issued upon such exercise See also Note 4C below.                        
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                                      
Loss Contingencies [Line Items]                                      
Offering costs                                     $ 10,000
Stock issued during period, value, new issues           $ 8,000                          
2013 Through June 30, 2025 [Member] | Israeli Innovation Authority [Member]                                      
Loss Contingencies [Line Items]                                      
Revenue grants received                           $ 1,878          
[1] Net of issuance costs in the amount of $2,683.
[2] Net of issuance costs of $328.
[3] Net of issuance costs of $333.